NeuroGenetic Pharmaceuticals Obtains New Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7afda954-04eb-4aee-ab6a-b64f917f067c&Preview=1
Date
1/5/2012
Company Name
NeuroGenetic Pharmaceuticals
Mailing Address
445 Marine View Ave Del Mar, CA 92014
Company Description
NeuroGenetic Pharmaceuticals is a privately held biotech company founded in 2009 with worldwide exclusive rights to a platform of gamma-secretase modulators.
Website
http://www.neurogeneticpharmaceuticals.com
Transaction Type
Venture Equity
Transaction Amount
Undisclosed
Transaction Round
Undisclosed
Proceeds Purposes
The funding will expedite the development of our lead candidate, NGP 555, for the prevention of AD, including achieving our immediate goal of initiating clinical trials.
M&A Terms
Venture Investor
Abbott Biotech Ventures